Literature DB >> 8828002

Neurobiology of cholecystokinin.

T H Moran1, G J Schwartz.   

Abstract

The peptide cholecystokinin (CCK) is widely distributed throughout the mammalian brain where it functions as a neurotransmitter and neuromodulator. CCK is colocalized with other neurotransmitters at a variety of brain sites. CCK receptor subtypes have been identified and their distributions mapped in the brain and the periphery. Exogenous CCK exerts a variety of effects depending on the site of administration, and many of these effects mimic actions of the endogenous peptide. Progress in understanding of the potential role of CCK in brain and behavior has focused on four main areas: CCK/dopamine interactions, CCK in anxiety and panic states, CCK in opioid nociception, and CCK in satiety. CCK's actions in modulating the activity of other neurotransmitters systems or in affecting behavior may serve as the bases for future therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8828002

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  22 in total

1.  Contributing mechanisms underlying desensitization of cholecystokinin-induced activation of primary nodose ganglia neurons.

Authors:  Cody W Kowalski; Jonathan E M Lindberg; Daniel K Fowler; Steven M Simasko; James H Peters
Journal:  Am J Physiol Cell Physiol       Date:  2020-02-19       Impact factor: 4.249

2.  Systemic cholecystokinin amplifies vago-vagal reflex responses recorded in vagal motor neurones.

Authors:  Edouard Viard; Richard C Rogers; Gerlinda E Hermann
Journal:  J Physiol       Date:  2011-12-12       Impact factor: 5.182

3.  Identification of cell-type-specific promoters within the brain using lentiviral vectors.

Authors:  J P Chhatwal; S E Hammack; A M Jasnow; D G Rainnie; K J Ressler
Journal:  Gene Ther       Date:  2007-01-18       Impact factor: 5.250

4.  Genetic analysis of a population heavy drinking phenotype identifies risk variants in whites.

Authors:  Ajna Hamidovic; Robert J Goodloe; Taylor R Young; Mindi A Styn; Kenneth J Mukamal; Helene Choquet; Jay L Kasberger; Sarah G Buxbaum; George J Papanicolaou; Wendy White; Kelly Volcik; Bonnie Spring; Brian Hitsman; Daniel Levy; Eric Jorgenson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

5.  Pathological satiety caused by brainstem hemangioblastoma.

Authors:  Debbie K Song; Russell R Lonser
Journal:  J Neurosurg Pediatr       Date:  2008-12       Impact factor: 2.375

6.  Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.

Authors:  Margery C Beinfeld; Lydiane Funkelstein; Thierry Foulon; Sandrine Cadel; Kouki Kitagawa; Thomas Toneff; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  Peptides       Date:  2009-07-07       Impact factor: 3.750

7.  Mechanisms of action of CCK to activate central vagal afferent terminals.

Authors:  Richard C Rogers; Gerlinda E Hermann
Journal:  Peptides       Date:  2008-07-04       Impact factor: 3.750

Review 8.  Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

Authors:  Susan Rotzinger; Franco J Vaccarino
Journal:  J Psychiatry Neurosci       Date:  2003-05       Impact factor: 6.186

9.  A tale of two circuits: CCKNTS neuron stimulation controls appetite and induces opposing motivational states by projections to distinct brain regions.

Authors:  Carolyn W Roman; Stephanie R Sloat; Richard D Palmiter
Journal:  Neuroscience       Date:  2017-07-03       Impact factor: 3.590

10.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.